Show Summary Details
Page of

Antiepileptic Drugs and Metabolic Disorders 

Antiepileptic Drugs and Metabolic Disorders
Chapter:
Antiepileptic Drugs and Metabolic Disorders
Author(s):

Ali A. Asadi-Pooya

and Michael R. Sperling

DOI:
10.1093/med/9780190214968.003.0014
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 23 August 2019

Three antiepileptic drugs—acetazolamide, topiramate, and zonisamide—are typically associated with metabolic acidosis due to their property of inhibiting the enzyme carbonic anhydrase. Hyponatremia occurs in patients treated with carbamazepine, oxcarbazepine, or eslicarbazepine acetate. Hyperammonemia can occur in as many as half of patients receiving valproic acid.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.